The short answer
Treatment differs by MPN type. It may include watchful waiting, removing blood to lower red-cell levels, medicines, targeted treatment, transfusions, spleen surgery, or stem cell transplant. The most useful conversation starts with the goal of treatment and the exact disease features driving the recommendation.
Which type you have drives the plan. Examples are polycythemia vera, essential thrombocythemia and primary myelofibrosis. NCI covers chronic myeloid leukemia on its own page.
NCI says these neoplasms usually get worse slowly, so expect the plan to change as counts and symptoms change.
Clotting and bleeding are both real risks. NCI says too many red cells, white cells or platelets can cause bleeding problems and clots, which can raise the risk of stroke or heart attack.
Sudden one-sided weakness, sudden speech or vision change, chest pain or sudden breathlessness are 911 symptoms, not same-day calls.
On this page
Choose how you want to read this
The whole article, with every detail and caution.
The short answer
Myeloproliferative neoplasms are a group of blood disorders in which your bone marrow (the soft tissue inside bones where blood is made) makes too many blood cells. This can mean too many red blood cells, white blood cells, or platelets. It depends on the specific type. NCI's list of these neoplasms includes:
- Polycythemia vera.
- Essential thrombocythemia.
- Primary myelofibrosis.
- Chronic neutrophilic leukemia.
- Chronic eosinophilic leukemia.
- Chronic myeloid leukemia, which NCI covers on its own page.
Treatment depends heavily on which specific type you have and how it is behaving.
Watchful waiting for people without symptoms
Your team may recommend watchful waiting instead of starting treatment right away. NCI defines watchful waiting as closely monitoring a condition without giving any treatment until signs or symptoms appear or change. NCI lists it for people under 60 with essential thrombocythemia who have no signs or symptoms and an acceptable platelet count, and as an early step in primary myelofibrosis. It is not a way of avoiding care. Ask your team what specific changes would prompt starting treatment for you.
Managing your blood counts directly
For polycythemia vera, NCI lists phlebotomy as a treatment. This means removing blood, similar to a blood donation. It lowers your red blood cell count. NCI also lists low-dose aspirin for polycythemia vera. For primary myelofibrosis, NCI lists red blood cell transfusions for anemia. A transfusion replaces blood cells destroyed by disease or cancer treatment.
Drug treatments
Hydroxyurea is a chemotherapy drug. NCI lists it for polycythemia vera and essential thrombocythemia. NCI lists chemotherapy for primary myelofibrosis too. Interferon works differently. NCI says it affects the division of cancer cells and can slow tumor growth. Ruxolitinib is a targeted therapy. NCI says it is used to treat polycythemia vera and certain types of myelofibrosis, and that targeted therapy blocks signals cancer cells need to grow. Which drug or combination fits you depends on your specific diagnosis, your symptoms, and your risk factors. Ask your team to explain their reasoning for your plan.
Surgery and stem cell transplant
NCI says splenectomy, surgery to remove the spleen, may be done if the spleen is enlarged. NCI lists stem cell transplant among the treatments for primary myelofibrosis in people with symptoms. Ask your team whether either one could apply to you, and what the risks are.
Why blood clots and bleeding are both real risks
NCI says too many red blood cells, white blood cells or platelets can cause bleeding problems and make clots form in blood vessels. This can raise the risk of stroke or heart attack. NCI says that with too many platelets, clots may form in blood vessels and there may also be increased bleeding. This is part of why regular blood count monitoring matters so much.
Which symptoms cannot wait
- Call 911 for sudden weakness or numbness on one side of your body, sudden trouble speaking, or sudden vision loss or change. CDC says to call 9-1-1 right away for these stroke signs.
- Call 911 for chest pain or sudden shortness of breath. CDC says to call 9-1-1 for heart attack symptoms. Do not phone the clinic first and wait for a call back. Do not drive yourself.
- Call 911 or go to the nearest emergency department for bleeding that will not stop with steady pressure, bleeding from your mouth or nose that will not stop, blood when you vomit, or black or bloody stools. NCI lists these as bleeding signs to report. MedlinePlus says to get medical help right away when bleeding cannot be controlled.
- Call your care team the same day for unusual bleeding or bruising that does settle. If you take hydroxyurea or other chemotherapy, call right away, day or night, instead of waiting for the same day.
What to expect long term
NCI says myeloproliferative neoplasms usually get worse slowly. Your treatment plan may change over time as your counts and symptoms change. Ask your team how often you will have blood tests and when to review whether your plan is still the right fit.
What to ask your care team
- Which specific type of myeloproliferative neoplasm do I have, and what does that mean for my treatment?
- Am I at higher risk for blood clots, and what is being done to lower that risk?
- What blood count changes would mean I need a different treatment?
- What symptoms should prompt a same-day or emergency call?
Sources
Common questions
Why might my team recommend waiting rather than treating?
NCI lists watchful waiting for some people, such as those under 60 with essential thrombocythemia and no symptoms, and as an early step in primary myelofibrosis. It is not a way of avoiding care. Ask what specific change in your counts or symptoms would prompt starting treatment.
What is phlebotomy and who has it?
Phlebotomy means removing blood, much like a blood donation, to lower the red blood cell count. It is a common treatment for polycythemia vera. NCI also lists low-dose aspirin among the treatments for polycythemia vera.
Which drugs are used?
Hydroxyurea, a chemotherapy drug, is listed by NCI for polycythemia vera and essential thrombocythemia. NCI says interferon affects the division of cancer cells and can slow tumor growth. Ruxolitinib is a targeted therapy that NCI lists for polycythemia vera and certain types of myelofibrosis. Which one fits depends on your type, symptoms and risk factors.
Which symptoms mean call 911 rather than the clinic?
Sudden weakness or numbness on one side, sudden trouble speaking, sudden vision loss or change, chest pain, or sudden shortness of breath. CDC says to call 911 right away for stroke signs and for heart attack symptoms. Do not phone the clinic and wait for a call back. Call 911 or go to the nearest emergency department for bleeding that will not stop.
Questions to ask your doctor
Being prepared helps you get the most out of your appointments. Save or print these questions.
Tap a question to save it to your list (kept on this device).
Your next step
Turn this guide into a short list for your care team.
Talk with a trained specialist or navigator
Cancer Explained provides educational guidance, but does not replace trained specialists, social workers, or your medical team.
Talk to a trained cancer information specialist
Free, confidential assistance from NCI Cancer Information Service via phone, chat, or email.
Contact your oncology team
Locate after-hours contact numbers, portal messages, or urgent triage phone lines.
Find a patient navigator
Get one-on-one help with appointments, logistics, translation, and care coordination.
Find a genetic counselor
Discuss inherited mutation risk, family history, and genetic testing options.
Find an oncology social worker
Access emotional counseling, family support groups, and mental health resources.
Find a financial navigator
Locate copay assistance foundations, grant programs, and lodging/travel support.
Find a clinical-trial specialist
Search matching studies and speak with NCI trial information specialists.
Get urgent help
Fever of 100.4°F (38°C) or higher during chemo, severe pain, or trouble breathing: call your cancer care team right away, day or night. Call 911 for an emergency.
Know someone who needs this?
Plenty of people are looking for something like this and do not know where to start. If this would help a friend or someone you love, send it on — we have written an opening line so you do not have to stare at an empty message. You can change every word of it.
Your message is written and sent in your own email or messaging app — we never see who you send it to, and nothing is added to any list.
Plain-language explanation of the published sources cited on this page. AI-assisted, source-checked, not clinician-reviewed.
Sources last checked: 2026-08-13 what this meansLast updated: 2026-09-29Next planned review: 2027-01-22
Review details and limits
Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes, and this is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.
Editorial status — Source checked. This page was written with AI assistance and then compared with the sources listed on it, looking for statements those sources do not back up. That check is not a sentence-by-sentence record and can miss errors. It is not a medical review, and it does not confirm the page is complete or right for your situation.
High-risk topic — talk to your care team. This topic can involve urgent, individual medical decisions. This page is general education only: it cannot tell you whether your situation is an emergency or what you personally should do. Follow your oncology team's instructions and contact them for individual guidance.
Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.
Words to know
Tap any term to see what it means.
How this page was created
Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes, and this is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.
Editorial status: Source checked — This page was written with AI assistance and then compared with the sources listed on it, looking for statements those sources do not back up. That check is not a sentence-by-sentence record and can miss errors. It is not a medical review, and it does not confirm the page is complete or right for your situation.
Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.
Read more about our editorial process, our use of AI, and our corrections policy.
Spotted a problem? Report an error — a factual mistake, broken or outdated source, confusing wording, or anything that seems unsafe. Please do not include names, medical record numbers, dates of birth, addresses, or other identifying medical information in your report.
After using this page, do you understand what to do next?
Anonymous — we only record the answer, never who gave it.